• An international team (British, French, German, Italian, Polish…) with complementary education and experience in the investment, medical, scientific, strategic and operational sectors


• Composed of alumni from: INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, Ponts et Chaussées, ESSEC, Imperial College, Dartmouth, etc.


• Professional backgrounds: Private Equity (3i, Siparex, USS Ltd, Barings, capiton), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC), Industry (Biotronik, Cerba, Pharmacy, Veterinary)

With offices in the US and Europe, ArchiMed is a leading investment firm focused exclusively on the healthcare industries. Its mix of operational, medical, scientific and financial expertise allows the ArchiMed team to serve as both a strategic and financial partner to European and North American small and middle-market businesses. Prioritized areas of focus include biopharmaceutical products & services, life science tools, medical devices & technologies, diagnostics, healthcare IT and consumer health. ArchiMed helps partners internationalize, acquire, innovate and expand their products and services. Over the last twenty years, ArchiMed’s leadership team has directly managed and invested in over eighty small to large-size healthcare companies globally, representing over €50 billion of combined value. ArchiMed manages over €5 billion in healthcare assets across its various funds. With investments dedicated to the healthcare sectors, ArchiMed aims to advance sustainable global healthcare industries through impactful investing.